title: Robotic radical prostatectomy at a teaching community hospital: outcomes and safety.
abstract: OBJECTIVE
  This study describes the early experience of robotic prostatectomy exclusively at a teaching community hospital.
  
  
  METHODS
  This is a retrospective report of 153 consecutive patients on whom 4 physicians were the operating surgeon.
  
  
  RESULTS
  The average hospital stay was 1.5 days, the mean operative time was 175 minutes, and the estimated operative blood loss was <300mL. The perioperative complication rate was 7.8% (12/153). The prostate-specific antigen failure rate was 2% (2/114). Urinary continence was maintained in 98% of patients 9 months after surgery. Postoperative Gleason scores differed significantly from preoperative biopsy results (P<0.001). Pathological records reported positive margins in 35% (54/153) of specimens. T3 tumors had positive margins more than twice as often as T2 tumors (P<0.002). Surgeon experience correlated with shorter operative times (P=0.001), but not with positive margins. Increasing body mass index was associated with increased operating time (P<0.001).
  
  
  CONCLUSIONS
  Robotic prostatectomy appears to be a safe and successful option for prostate cancer treatment in a teaching community hospital.
authors: Ohio State University College of Medicine, Columbus, Ohio, USA.
authors: Julianna
authors: J
authors: Padavano
authors: Lynn
authors: L
authors: Shaffer
authors: Elizabeth
authors: E
authors: Fannin
authors: John
authors: J
authors: Burgers
authors: Wayne
authors: W
authors: Poll
authors: Eric S
authors: ES
authors: Ward
authors: Kevin
authors: K
authors: Banks
authors: Jeffrey G
authors: JG
authors: Bell
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006764:Hospitals, Community; D006784:Hospitals, Teaching; D006801:Humans; D008297:Male; D008875:Middle Aged; D059035:Perioperative Period; D017430:Prostate-Specific Antigen / Q000032:analysis; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000601:surgery*; D011788:Quality of Life; D012189:Retrospective Studies; D012371:Robotics; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000453:epidemiology
chemical_list: D017430:Prostate-Specific Antigen